Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

(2/6) ASCO 2017: LATITUDE data

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(2/6) ASCO 2017: LATITUDE data ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017

(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate cancer

Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017

Treating the patient, not the disease: in memory of Umberto Veronesi

Prof Gordon McVie - Editor in Chief, ecancer
Treating the patient, not the disease: in memory of Umberto Veronesi ( Prof Gordon McVie - Editor in Chief, ecancer )
8 Jun 2017

Clinical potential of trastuzumab biosimilar CTP6

Prof Francisco Esteva - NYU Langone Medical Center, New York, USA
Clinical potential of trastuzumab biosimilar CTP6 ( Prof Francisco Esteva - NYU Langone Medical Center, New York, USA )
8 Jun 2017

ASCO 2017: Round up

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ASCO 2017: Round up ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
6 Jun 2017

Updates in melanoma: Treating BRAF and brain metastases

Prof Georgina Long - University of Sydney, Sydney, Australia
Updates in melanoma: Treating BRAF and brain metastases ( Prof Georgina Long - University of Sydney, Sydney, Australia )
5 Jun 2017

Bendamustine for indolent lymphoma reduces relapse after 10 years

Dr Mathias Rummel - University of Giessen, Giessen, Germany
Bendamustine for indolent lymphoma reduces relapse after 10 years ( Dr Mathias Rummel - University of Giessen, Giessen, Germany )
5 Jun 2017

ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year

Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year ( Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy )
5 Jun 2017

T-VEC and checkpoint therapy for melanoma

Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA
T-VEC and checkpoint therapy for melanoma ( Prof Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )
5 Jun 2017

Prevalence of homologous recombination deficiency among 53,000 tumour samples

Dr Arielle Heeke - Georgetown Lombardi Comprehensive Cancer Center, Washington, USA
Prevalence of homologous recombination deficiency among 53,000 tumour samples ( Dr Arielle Heeke - Georgetown Lombardi Comprehensive Cancer Center, Washington, USA )
5 Jun 2017

Natural plant based balm antidote to severe nail toxicity during chemotherapy

Dr Robert Thomas - Cambridge University Hospitals, Cambridge, UK
Natural plant based balm antidote to severe nail toxicity during chemotherapy ( Dr Robert Thomas - Cambridge University Hospitals, Cambridge, UK )
5 Jun 2017

Dacomitinib for EGFR positive lung cancer

Dr Tony Mok, The Chinese University of Hong Kong, Shatin, China
Dacomitinib for EGFR positive lung cancer ( Dr Tony Mok, The Chinese University of Hong Kong, Shatin, China )
5 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation